Monopar Therapeutics (MNPR) Appoints Octávio Costa, MD, as Chief Medical Officer
Go back to Monopar Therapeutics (MNPR) Appoints Octávio Costa, MD, as Chief Medical Officer| (NASDAQ: MNPR) | Delayed: 118.55 +2.27 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.28 | 52 Week High | $ | |||
| Open | $117.44 | 52 Week Low | $ | |||
| Day High | $121.02 | P/E | N/A | |||
| Day Low | $115.07 | EPS | $ | |||
| Volume | 208,568 | |||||

